After 21 days of ITE administration, compared with the vehicle-treated mice, there was a significant inhibition in the growth of the transplanted tumours (Fig. 4g, Supplementary Fig. 39 and Supplementary Fig. 40), and this was accompanied by a general reduction in the Oct4 level (Supplementary Fig. 40). The gene discussed is POU5F1; the disease is neoplasm.